Riggs Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Riggs Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-187	Closed	-$7.39K	–	453
2025 Q2	$7.39K	Sell	187 -63	-25%	-$2.06K	﹤0.01%	387
2025 Q1	$7.54K	Hold	250	–	–	﹤0.01%	288
2024 Q4	$8.73K	Hold	250	–	–	﹤0.01%	270
2024 Q3	$10K	Hold	250	–	–	﹤0.01%	254
2024 Q2	$11.9K	Sell	250 -32	-11%	-$1.31K	﹤0.01%	241
2024 Q1	$12.2K	Buy	282 +32	+13%	+$1.52K	﹤0.01%	230
2023 Q4	$12.6K	Sell	250 -250	-50%	-$12K	﹤0.01%	225
2023 Q3	$22.7K	Hold	500	–	–	0.01%	181
2023 Q2	$20.5K	Hold	500	–	–	0.01%	189
2023 Q1	$17.9K	Hold	500	–	–	0.01%	188
2022 Q4	$18.9K	Sell	500 -497	-50%	-$20.9K	0.01%	172
2022 Q3	$44K	Hold	997	–	–	0.02%	139
2022 Q2	$37K	Hold	997	–	–	0.02%	146
2022 Q1	$37K	Hold	997	–	–	0.01%	166
2021 Q4	$30K	Hold	997	–	–	0.01%	181
2021 Q3	$33K	Sell	997 -3	-0.3%	-$113	0.01%	171
2021 Q2	$40K	Hold	1,000	–	–	0.01%	167
2021 Q1	$45K	Hold	1,000	–	–	0.01%	149
2020 Q4	$57K	Sell	1,000 -4,400	-81%	-$219K	0.02%	125
2020 Q3	$166K	Buy	5,400 +4,400	+440%	+$244K	0.07%	68
2020 Q2	$58K	Hold	1,000	–	–	0.02%	98
2020 Q1	$47K	Hold	1,000	–	–	0.03%	103
2019 Q4	$60K	Hold	1,000	–	–	0.02%	117
2019 Q3	$59K	Hold	1,000	–	–	0.03%	112
2019 Q2	$64K	Hold	1,000	–	–	0.04%	103
2019 Q1	$81K	Hold	1,000	–	–	0.06%	86
2018 Q4	$54K	Hold	1,000	–	–	0.04%	96
2018 Q3	$51K	Hold	1,000	–	–	0.02%	105
2018 Q2	$42K	Hold	1,000	–	–	0.02%	118
2018 Q1	$44K	Hold	1,000	–	–	0.02%	124
2017 Q4	$50K	Hold	1,000	–	–	0.02%	117
2017 Q3	$51K	Hold	1,000	–	–	0.02%	122
2017 Q2	$51K	Hold	1,000	–	–	0.02%	126
2017 Q1	$40K	Hold	1,000	–	–	0.02%	126
2016 Q4	$48K	Hold	1,000	–	–	0.02%	114
2016 Q3	$37K	Hold	1,000	–	–	0.02%	129
2016 Q2	$23K	Hold	1,000	–	–	0.01%	149
2016 Q1	$41K	Hold	1,000	–	–	0.03%	110
2015 Q4	$62K	Hold	1,000	–	–	0.03%	96
2015 Q3	$40K	Hold	1,000	–	–	0.02%	107
2015 Q2	$58K	Hold	1,000	–	–	0.03%	96
2015 Q1	$64K	Hold	1,000	–	–	0.03%	95
2014 Q4	$62K	Hold	1,000	–	–	0.03%	96
2014 Q3	$39K	Buy	+1,000	New	+$35.4K	0.02%	116

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riggs Asset Management's IONS Position: Q3 2025 in Review

Riggs Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2025, closing a stake of 187 shares — an estimated $7.39K sold.

Riggs Asset Management first reported a position in IONS in Q3 2014 and held it in 44 quarters. The position peaked at $166K in Q3 2020. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

Riggs Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Riggs Asset Management sold 187 Ionis Pharmaceuticals shares in Q3 2025, an estimated $7.39K.
Riggs Asset Management first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 44 quarters.
Riggs Asset Management's Ionis Pharmaceuticals position peaked at $166K in Q3 2020.
435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.